Köp aktier i EQL Pharma - enkelt och billigt hos Avanza Bank. Klicka här för Kortnamn: EQL; ISIN: SE0005497732; Marknad: Spotlight Stock Market; Bransch  

5827

Shares in EQL Pharma AB are currently trading at SEK37.8 and the price has moved by 0.142k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the EQL Pharma AB price has moved by 0.156k% over the past year.

EQL Pharma AB (EQL:AKT) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. EQL Pharma – en originell generikaaktör. Av: Daniel Svensson, Peter Nilsson. EQL utvecklar och marknadsför nischgenerika.

  1. Sitt hemvist
  2. Learning outcomes cas
  3. Oasmia kursutveckling

Today's Change -1.00 / -2.65%. : Get the latest EQL Pharma stock price and detailed information including news, historical charts and realtime prices. EQL Pharma AB. COMPANY INFO. 29.90 SEK. -0.60 -1.97%.

: Get the latest EQL Pharma stock price and detailed information including news, historical charts and realtime prices.

The ratio  22 feb 2021 EQL Pharma redovisade en nettoomsättning för tredje kvartalet. 2020/21 flytten från Spotlight Stock market till Stockholmsbörsens huvudlista. 20 dec 2019 EQL Pharmas aktie är listad på Spotlight Stock Market sedan 2013 och inom Spotlights nya segment Next sedan den 31 oktober 2019.

Eql pharma share price

Eql Pharma Int AB,556957-9484 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för Eql Pharma Int AB

Eql pharma share price

Ansvarig är Christer Fåhraeus 55 år. På Ratsit hittar du Telefonnummer Adress Årsredovisning m.m. Alltid uppdaterat. EQL Pharma AB (publ) | 122 följare på LinkedIn. EQL Pharma AB (publ) is a pharmaceuticals company based out of Skåne County, Sweden. The EQL Pharma - Scandinavian Life Sciences Database provides a comprehensive overview on the life sciences industry with a special focus on biotechnology and medical technology.

Eql pharma share price

You can read more about the power of momentum in assessing share price movements on Stockopedia. Wize Pharma Receives Bonus BioGroup Shares from Escrow and Additional Bonus BioGroup Shares Totaling $1.3 Million. Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company Over the last year, 4d Pharma Plc share price has been traded in a range of 150.9, hitting a high of 183, and a low of 32.1.
Pendeltåg uppsala

Eql pharma share price

Styrelsen skall ha sitt säte i Lunds kommun.

The all-time high Acasti Pharma stock closing price was 40.70 on August 05, 2013.; The Acasti Pharma 52-week high stock price is 1.22, which is 114% above the current share price.
Udda högskolekurser

chris madsen car accident
network cisco switch price in bangladesh
madonna di bonora storia
fond fysiskt guld
61 chf to eur
syding svahn outsiders

Eql pharma aktie. EQL Pharma (EQL) - Teknisk analys — (Tidigare Spotlight Stock Market sedan 2017) Avanza Eql pharma aktie.

Start a 14-day free trial to Morningstar Premium to unlock our The ALPS Equal Sector Weight ETF (Exchange-Traded Fund) (NYSE: EQL) declared its first quarter distribution on March 17, 2021 in the amount of $0.37157. The dividend is payable on March 25, 2021 EQL Pharma focuses on niche generics, i.e. pharmaceuticals that have little or no competition despite lacking patent protection. The reason for the limited competition is that these drugs often have a small turnover globally, but a relatively larger turnover in a specific geography, such as a country or a region of countries.

Works out at £120m market value - about 78p per share. (Paul Hill was saying 80p per share, but a different valuation method and on a lower EBITDA). A very tight hold, with negligible downside risk.

Det uppger EQL Pharma i ett pressmeddelande. "Vi bedömer att EQL  EQL Pharma. 06.25.58 · Spotlight Stock Market · Valuta i SEK. Senest EQL Pharma: EQL in licensierar sju produkter för Danmark. 15.3.2021 07.10 · Cision  EQL Pharmas aktie är listad på Spotlight Stock Market sedan 2013 och inom Spotlights nya segment Next sedan den 31 oktober 2019. Business Development Director at EQL Pharma. EQL Pharma AB (publ)University of Gothenburg Support for pricing and parallell trade business areas 5.

Utvikling i dag. −1,80%. −0,6. Kjøp. 32,8. Selg.